An interventional study of ASL Services in Deafness and Hearing Loss, sponsored by University of Connecticut. Active, not recruiting at 1 site in United States. Open to participants aged 2 Years and older. Per ClinicalTrials.gov, last updated 2025-07-11.
Sponsored by University of Connecticut · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 63 studies in Deafness with a site in United States — 19 open to participants now, 22 under way, 1 of them phase 3. Deafness · United States.
Among the 63 studies in Deafness with a site in United States, this one is the 23rd largest by planned enrollment of the 44 interventional ones that give a count, is one of 3 that started in 2021, is one of 31 with no phase, reaches primary completion later than 2 of the 21 other live ones, and was the 41st registered.
161 studies on the registry are indexed under Deafness; 46 are open to participants now.
Browse Deafness studies →19 of the 63 studies in Deafness with a site in United States are open now. Recruiting first, the newest first:
Massachusetts Eye and Ear Infirmary · Sites in United States
Ages 18–80
Skylark Bio Inc. · Sites in United States
Ages 9 mo–7 yrs
Craig D. Workman, PhD · Sites in United States
Ages 18–99
Massachusetts Eye and Ear Infirmary · Sites in United States
Ages 18–85
Eli Lilly and Company · Sites in United States, Canada, Taiwan and 1 more country
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 30 Deafness studies recruiting now, 11 (37%) set no upper age limit and 10 (33%) stop at 75 or younger; 19 take children under 18; 5 take healthy volunteers.
This study: 2 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
63 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 5 · Phase 3 2 · Phase 4 1
First in 1997; this study’s year is marked. 3 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is close to the median of 42 across 107 interventional studies indexed under Deafness.
Median enrollment 41 across the 44 interventional studies, 249 across the 19 observational. Of the 34 that completed or were terminated, 14 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 63 have an industry lead sponsor. The 10 most frequent:
University of Connecticut is the lead sponsor of 136 studies on the registry; 20 are open to participants now.
University of Connecticut has 1 study filed under Deafness — fewer than ten, so there is no comparison to draw.
9 of the studies in Deafness with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05176561Gallaudet UniversityAuditory-Cognitive Training to Optimize Outcomes for Older CI Users | 2026-11 |
| NCT06960616Massachusetts Eye and Ear InfirmaryImproving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy | 2026-11-26 |
| NCT01694940Columbia UniversityNorth American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) | 2026-12-31 |
| NCT05203302NYU Langone HealthNovel Coding Strategies for Children With Cochlear Implants | 2027-01-01 |
| NCT06901674NYU Langone HealthStimulating the Cochlear Apex Without Longer Electrodes | 2027-01-01 |
Add all 9 to your calendar (.ics) → With an account.
Among the 63 studies in Deafness with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study examines the development of American Sign Language by deaf and hard of hearing (DHH) children and their parents.
After being informed about the study and potential risks, adult participants who give written informed consent and children whose parents who give written permission will be enrolled in the study. They will participate in preliminary language tasks to assess baseline performance on American Sign Language (ASL) measures. Subsequently they will have weekly sessions with an ASL Specialist to support their development of ASL, following a 6-week on/6-week off ABABABAB sequence.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Children:
Adults:
- One adult caregiver for each child
Exclusion Criteria:
Presence (or absence, across 6-week periods) of ASL services designed to support improvement in ASL fluency
Behavioral: ASL Services
Presence (or absence, across 6-week periods) of ASL services designed to support improvement in ASL fluency
Behavioral: ASL Services
ASL specialist meets with participants and provides ASL instruction
Change from Baseline in ASL Phonological Production Accuracy over 12 Months
Participants copy ASL signs produced on video; their productions are scored for phonological accuracy and reported as percent correct out of all possible phonological features. Weekly measures are taken for SCD analysis.
Time frame: Baseline and 12 months
Change from Baseline in ASL Production Frequency over 12 Months
Participants engage in naturalistic play sessions which are videorecorded. Sessions are analyzed for the number of productions in ASL over a 15-minute period. Weekly measures are taken for SCD analysis.
Time frame: Baseline and 12 months
Plan to share: Yes — De-identified data from language tasks
Time frame: After (or with) publication of the results
Access criteria: De-identified numerical coding scores will be shared using an open science site that is generally accessible
No publications or documents are linked to this record.
Started Jul 2021 (actual). Primary completion is estimated for Nov 2025, 52 months after the start.
Of 50 non-industry interventional studies with no phase under Deafness, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 20. This study's planned 52 months is above that.
Counting every sponsor, half of 58 studies reached it within 31 months; a quarter within 17.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.